We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HST icon
5576
CALL
Host Hotels & Resorts
HST
$15.7B
$472K ﹤0.01%
23,800
-33,900
-59% -$664K
DF
5577
CALL
DELISTED
Dean Foods Company
DF
$472K ﹤0.01%
40,800
+17,600
+76% +$187K
AUSE
5578
DELISTED
WisdomTree Australia Dividend Fund
AUSE
$472K ﹤0.01%
7,920
-2,740
-26% -$158K
DRN icon
5579
CALL
Direxion Daily Real Estate Bull 3X ETF
DRN
$45.4M
$471K ﹤0.01%
+20,600
New +$473K
SWCH
5580
CALL
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$471K ﹤0.01%
+25,900
New +$473K
AMPE
5581
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$471K ﹤0.01%
386
+219
+131% +$103K
GM.WS.B
5582
DELISTED
General Motors Company
GM.WS.B
$471K ﹤0.01%
20,179
+5,407
+37% +$138K
WBIF icon
5583
WBI BullBear Value 3000 ETF
WBIF
$23.6M
$470K ﹤0.01%
16,269
+2,107
+15% +$58.3K
GYLD icon
5584
Arrow Dow Jones Global Yield ETF
GYLD
$37.9M
$469K ﹤0.01%
26,051
+11,919
+84% +$216K
PBD icon
5585
Invesco Global Clean Energy ETF
PBD
$195M
$469K ﹤0.01%
35,686
+19,746
+124% +$255K
USFD icon
5586
PUT
US Foods
USFD
$23.6B
$469K ﹤0.01%
+14,700
New +$416K
AVT icon
5587
PUT
Avnet
AVT
$7.86B
$468K ﹤0.01%
11,800
-1,100
-9% -$44K
NPO icon
5588
PUT
Enpro
NPO
$7.27B
$468K ﹤0.01%
5,000
+1,000
+25% +$84.7K
QTWO icon
5589
CALL
Q2 Holdings
QTWO
$4.04B
$468K ﹤0.01%
12,700
+2,200
+21% +$90.1K
SEM
5590
PUT
DELISTED
Select Medical
SEM
$468K ﹤0.01%
+49,184
New +$470K
CUTR
5591
CALL
DELISTED
Cutera, Inc.
CUTR
$467K ﹤0.01%
10,300
+1,000
+11% +$42.2K
ESIO
5592
PUT
DELISTED
Electro Scientific Industries
ESIO
$467K ﹤0.01%
+21,800
New +$438K
PAGG
5593
DELISTED
Invesco Global Agriculture ETF
PAGG
$467K ﹤0.01%
17,004
-16,179
-49% -$431K
DLTH icon
5594
CALL
Duluth Holdings
DLTH
$153M
$466K ﹤0.01%
+26,100
New +$483K
SCL icon
5595
PUT
Stepan Co
SCL
$1.48B
$466K ﹤0.01%
5,900
+3,200
+119% +$263K
ENR icon
5596
PUT
Energizer
ENR
$1.56B
$465K ﹤0.01%
9,700
+4,400
+83% +$202K
ERX icon
5597
Direxion Daily Energy Bull 2X ETF
ERX
$251M
$465K ﹤0.01%
+1,330
New +$403K
GPRE icon
5598
PUT
Green Plains
GPRE
$1.09B
$465K ﹤0.01%
27,600
+2,800
+11% +$49.2K
PWOD
5599
DELISTED
Penns Woods Bancorp
PWOD
$465K ﹤0.01%
+14,982
New +$479K
RVNC
5600
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
$465K ﹤0.01%
13,000
+5,400
+71% +$155K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.